Head-to-head · WeighScore
DrMedHealth vs Rixa Health
The verdict
DrMedHealth takes it — 66.2/100 to 60.5/100.
DrMedHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DrMedHealth is a LegitScript-certified US telehealth platform for GLP-1 medical weight loss.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | DrMedHealth | Rixa Health |
|---|---|---|
| WeighScore | 66.2/100 | 60.5/100 |
| Grade | C | C |
| Scorecard rank | #198 | #321 |
| Semaglutide | $199/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide | $299/mo (starting dose, compounded) | Not disclosed |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #198 · C
Strengths
- LegitScript certified telehealth platform
- Low compounded pricing: semaglutide from $199/mo, tirzepatide from $299/mo
- Both compounded and FDA-approved branded options available
- Fast physician review (advertised ~2 hours) with free shipping
- Compounded by licensed US pharmacies
Where it loses points
- Compounded GLP-1s are not FDA-approved for safety, efficacy or quality
- Cash-pay model; insurance generally not accepted for medication
- Full list of available states not consolidated in one place
- Site is JavaScript-rendered, limiting easy review of full terms
Graded #321 · C
Strengths
- Functional-medicine, root-cause clinical approach
- Compounded and oral semaglutide plus tirzepatide offered
- Board-certified DO and FNP providers with years of experience
- Medication bundled with visits into a single price
- No charge until after approval
Where it loses points
- No public monthly pricing; quoted only during consultation
- Relies on compounded GLP-1, which is not FDA-approved as a finished drug
- A handful of states still listed as coming soon
- Branded GLP-1 medications are not the primary offering
- Requires ongoing monthly follow-up commitment
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.